Annual Working Capital
$347.61 M
-$48.82 M-12.31%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual working capital is $347.61 million, with the most recent change of -$48.82 million (-12.31%) on December 31, 2023.
- During the last 3 years, AUPH annual working capital has fallen by -$39.82 million (-10.28%).
- AUPH annual working capital is now -26.46% below its all-time high of $472.68 million, reached on December 31, 2021.
Performance
AUPH Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$361.85 M
+$29.09 M+8.74%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly working capital is $361.85 million, with the most recent change of +$29.09 million (+8.74%) on September 30, 2024.
- Over the past year, AUPH quarterly working capital has increased by +$29.09 million (+8.74%).
- AUPH quarterly working capital is now -23.45% below its all-time high of $472.68 million, reached on December 31, 2021.
Performance
AUPH Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
AUPH Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -12.3% | +8.7% |
| 3 y3 years | -10.3% | -13.4% |
| 5 y5 years | +176.8% | -13.4% |
AUPH Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -26.5% | at low | -23.4% | +10.6% |
| 5 y | 5-year | -26.5% | +14.4% | -23.4% | +38.7% |
| alltime | all time | -26.5% | +8891.4% | -23.4% | +9251.5% |
Aurinia Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $361.85 M(+8.7%) |
| Jun 2024 | - | $332.76 M(+1.7%) |
| Mar 2024 | - | $327.17 M(-5.9%) |
| Dec 2023 | $347.61 M(-12.3%) | $347.61 M(-1.4%) |
| Sep 2023 | - | $352.58 M(-0.5%) |
| Jun 2023 | - | $354.25 M(-7.2%) |
| Mar 2023 | - | $381.60 M(-3.7%) |
| Dec 2022 | $396.43 M(-16.1%) | $396.43 M(-5.1%) |
| Sep 2022 | - | $417.94 M(-0.2%) |
| Jun 2022 | - | $418.57 M(-5.7%) |
| Mar 2022 | - | $443.78 M(-6.1%) |
| Dec 2021 | $472.68 M(+22.0%) | $472.68 M(+62.1%) |
| Sep 2021 | - | $291.68 M(-9.0%) |
| Jun 2021 | - | $320.37 M(-8.8%) |
| Mar 2021 | - | $351.10 M(-9.4%) |
| Dec 2020 | $387.43 M(+27.5%) | $387.43 M(-0.1%) |
| Sep 2020 | - | $387.75 M(+48.6%) |
| Jun 2020 | - | $260.88 M(-8.1%) |
| Mar 2020 | - | $283.72 M(-6.6%) |
| Dec 2019 | $303.84 M(+141.9%) | $303.84 M(+142.8%) |
| Sep 2019 | - | $125.12 M(-4.6%) |
| Jun 2019 | - | $131.22 M(-9.5%) |
| Mar 2019 | - | $144.93 M(+15.4%) |
| Dec 2018 | $125.59 M(-24.8%) | $125.59 M(-8.4%) |
| Sep 2018 | - | $137.16 M(-7.8%) |
| Jun 2018 | - | $148.72 M(-5.1%) |
| Mar 2018 | - | $156.67 M(-6.2%) |
| Dec 2017 | $167.10 M(+399.0%) | $167.10 M(-6.1%) |
| Sep 2017 | - | $178.03 M(-5.7%) |
| Jun 2017 | - | $188.86 M(-3.7%) |
| Mar 2017 | - | $196.16 M(+485.8%) |
| Dec 2016 | $33.49 M(+159.3%) | $33.49 M(+166.7%) |
| Sep 2016 | - | $12.56 M(+25.8%) |
| Jun 2016 | - | $9.98 M(+33.8%) |
| Mar 2016 | - | $7.46 M(-42.2%) |
| Dec 2015 | $12.92 M(-57.9%) | $12.92 M(-25.9%) |
| Sep 2015 | - | $17.44 M(-22.7%) |
| Jun 2015 | - | $22.56 M(-17.0%) |
| Mar 2015 | - | $27.17 M(-11.5%) |
| Dec 2014 | $30.71 M(-876.8%) | $30.71 M(-11.0%) |
| Sep 2014 | - | $34.53 M(-3.8%) |
| Jun 2014 | - | $35.88 M(-8.1%) |
| Mar 2014 | - | $39.04 M(-1087.4%) |
| Dec 2013 | -$3.95 M(+22.6%) | -$3.95 M(+80.4%) |
| Sep 2013 | - | -$2.19 M(-42.2%) |
| Jun 2013 | - | -$3.79 M(-1.3%) |
| Mar 2013 | - | -$3.84 M(+19.1%) |
| Dec 2012 | -$3.23 M(-152.1%) | -$3.23 M(-1611.7%) |
| Sep 2012 | - | $213.40 K(-88.8%) |
| Jun 2012 | - | $1.90 M(-54.1%) |
| Mar 2012 | - | $4.15 M(-33.0%) |
| Dec 2011 | $6.19 M | $6.19 M(-39.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $10.19 M(+6.1%) |
| Jun 2011 | - | $9.60 M(+23.4%) |
| Mar 2011 | - | $7.78 M(+48.7%) |
| Dec 2010 | $5.24 M(+142.4%) | $5.24 M(-15.5%) |
| Sep 2010 | - | $6.19 M(+105.6%) |
| Jun 2010 | - | $3.01 M(-6.4%) |
| Mar 2010 | - | $3.22 M(+49.0%) |
| Dec 2009 | $2.16 M(-82.9%) | $2.16 M(-33.8%) |
| Sep 2009 | - | $3.26 M(-17.5%) |
| Jun 2009 | - | $3.95 M(+15.3%) |
| Mar 2009 | - | $3.43 M(-72.8%) |
| Dec 2008 | $12.62 M(-48.7%) | $12.62 M(-29.4%) |
| Sep 2008 | - | $17.86 M(-28.3%) |
| Jun 2008 | - | $24.91 M(+30.3%) |
| Mar 2008 | - | $19.12 M(-22.2%) |
| Dec 2007 | $24.58 M(+47.2%) | $24.58 M(-24.9%) |
| Sep 2007 | - | $32.73 M(-12.2%) |
| Jun 2007 | - | $37.30 M(-12.8%) |
| Mar 2007 | - | $42.76 M(+156.0%) |
| Dec 2006 | $16.70 M(-55.2%) | $16.70 M(-32.0%) |
| Sep 2006 | - | $24.55 M(-19.8%) |
| Jun 2006 | - | $30.62 M(-5.9%) |
| Mar 2006 | - | $32.55 M(-12.8%) |
| Dec 2005 | $37.31 M(-20.7%) | $37.31 M(-19.8%) |
| Sep 2005 | - | $46.51 M(+36.8%) |
| Jun 2005 | - | $33.98 M(-16.7%) |
| Mar 2005 | - | $40.81 M(-13.2%) |
| Dec 2004 | $47.02 M(-20.0%) | $47.02 M(-8.3%) |
| Sep 2004 | - | $51.28 M(-2.6%) |
| Jun 2004 | - | $52.67 M(-5.0%) |
| Mar 2004 | - | $55.47 M(-5.6%) |
| Dec 2003 | $58.75 M(+43.9%) | $58.75 M(-6.4%) |
| Sep 2003 | - | $62.77 M(+16.4%) |
| Jun 2003 | - | $53.94 M(+38.9%) |
| Mar 2003 | - | $38.85 M(-4.9%) |
| Dec 2002 | $40.84 M(+22.8%) | $40.84 M(-8.6%) |
| Sep 2002 | - | $44.68 M(-2.4%) |
| Jun 2002 | - | $45.77 M(+39.8%) |
| Mar 2002 | - | $32.74 M(+33.5%) |
| Dec 2001 | $33.27 M(+190.7%) | - |
| Aug 2001 | - | $24.52 M(+191.8%) |
| May 2001 | - | $8.40 M(-15.3%) |
| Feb 2001 | - | $9.92 M(-13.3%) |
| Nov 2000 | $11.44 M(+426.5%) | $11.44 M(+11.7%) |
| Aug 2000 | - | $10.24 M(-1.0%) |
| May 2000 | - | $10.34 M(+241.2%) |
| Feb 2000 | - | $3.03 M(+39.5%) |
| Nov 1999 | $2.17 M(-223.6%) | $2.17 M(>+9900.0%) |
| Aug 1999 | - | $0.00(-100.0%) |
| May 1999 | - | -$67.80 K(<-9900.0%) |
| Feb 1999 | - | $0.00 |
| Nov 1998 | -$1.76 M | - |
FAQ
- What is Aurinia Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual working capital year-on-year change?
- What is Aurinia Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly working capital year-on-year change?
What is Aurinia Pharmaceuticals annual working capital?
The current annual working capital of AUPH is $347.61 M
What is the all time high annual working capital for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual working capital is $472.68 M
What is Aurinia Pharmaceuticals annual working capital year-on-year change?
Over the past year, AUPH annual working capital has changed by -$48.82 M (-12.31%)
What is Aurinia Pharmaceuticals quarterly working capital?
The current quarterly working capital of AUPH is $361.85 M
What is the all time high quarterly working capital for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly working capital is $472.68 M
What is Aurinia Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, AUPH quarterly working capital has changed by +$29.09 M (+8.74%)